|
⚲
|
| Keyboard |
| Platinum Management Ny LLC | |
|---|---|
| Firm | |
| Address | 250 West 55th Street 14th Floor New York, NY 10019 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Platinum Partners Value Arbitrage Fund International Ltd | 021-51507 | Promoter | 967.5 M | ||
| Platinum Partners Value Arbitrage Fund USA LP | 021-51506 | Promoter | 516.5 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Echo Therapeutics Inc ECTE
Warrants · derivative
|
2014-12-18 | Buy | 1 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Series F Preferred Stock · derivative
|
2014-12-18 | Buy | 420,168 | $1.19 | 500,000 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock, par value $0.001
|
2014-09-02 | Sell | 60,000 | $1.36 | 81,600 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-30 | Buy | 55,083 | $2.20 | 121,183 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-27 | Buy | 10,656 | $2.20 | 23,443 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-26 | Buy | 15,000 | $2.20 | 33,000 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-25 | Buy | 2,300 | $2.20 | 5,060 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-24 | Buy | 386 | $2.20 | 849 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-23 | Buy | 85 | $2.20 | 187 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2014-06-20 | Buy | 16,490 | $2.20 | 36,278 |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2013-12-10 | Buy | 55,655 | $2.75 | 153,051 |
|
Echo Therapeutics Inc ECTE
Warrants · derivative
|
2013-12-10 | Buy | 1 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Series E Preferred Stock · derivative
|
2013-12-10 | Buy | 1,398,890 | $2.75 | 3,846,948 |
|
Echo Therapeutics Inc ECTE
Series E Preferred Stock · derivative
|
2013-12-10 | Buy | 349,723 | $2.75 | 961,738 |
|
Echo Therapeutics Inc ECTE
Warrants · derivative
|
2013-12-10 | Buy | 1 | $0.00 | |
|
Echo Therapeutics Inc ECTE
Common Stock
|
2013-12-10 | Buy | 13,914 | $2.75 | 38,264 |